Interferon regulatory factor 4 (IRF4) is a transcription factor that regulates normal and malignant immune cell development and is implicated in multiple myeloma pathogenesis. This protocol describes the use of combined cell surface and intranuclear staining with fluorescent antibodies to measure IRF4 protein expression within myeloma and normal immune cells. IRF4 protein quantification may provide a valuable prognostic tool to predict disease severity and sensitivity to IRF4-targeted therapies. This flow-cytometry-based procedure could also be rapidly translated into a clinically compatible assay. For complete details on the use and execution of this protocol, please refer to Mondala et al. (2021).
Pubmed ID: 34136833 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsThis monoclonal targets CD16/CD32
View all literature mentionsThis monoclonal targets CD138
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets IRF4
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsCell line RPMI-8226 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line NCI-H929 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions